✦ LIBER ✦

An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer

✍ Scribed by Heather J. Dalton; Xinhua Yu; Lilian Hu; Daniel S. Kapp; Ivor Benjamin; Bradley J. Monk; John K. Chan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An economic analysis of intravenous carb

✍ H. Dalton; X. Yu; L. Hu; B. Monk; I. Benjamin; J. Chan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Dose-dense paclitaxel once a week in com

✍ Noriyuki Katsumata; Makoto Yasuda; Fumiaki Takahashi; Seiji Isonishi; Toshiko Jo 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 197 KB

Comparison of weekly versus every 3 week

✍ Ta-Chen Huang; Toby C. Campbell 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 479 KB

Randomized phase 3 trial of interferon g

✍ David S. Alberts; Christian Marth; Ronald D. Alvarez; Gary Johnson; Mariusz Bidz 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Treatment of patients with advanced ovar

✍ W. Schröder; A. du Bois; W. Kuhn; H.J. Lück; V. Möbus; W. Meier; U. Nitz; S. Olb 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 149 KB

A phase II study of modified dose-dense

✍ L. Abaid; J. Micha; M. Rettenmaier; J. Brown; A. Mendivil; K. Lopez; B. Goldstei 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB